BRUCE DOWNEY
CIK 1237257 · Chairman & CEO · last filed 2024-06-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.17M
Companies
5
Total Filings
46
Lifetime Open-Market Net
-$188.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CCCC | Director | 489,542 | $3.76 | $1.84M | $0 | 6 | 2024-06-21 |
| CAH | Director | 53,929 | $247.18 | $13.33M | $0 | 16 | 2022-11-10 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Director | 0 | — | — | -$188.6K | 15 | 2020-10-01 |
| MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted | Director | — | — | — | $0 | 2 | 2019-06-12 |
| BARR PHARMACEUTICALS INC (BRL) Delisted | Chairman & CEO | — | — | — | $0 | 4 | 2008-11-24 |
Recent Filings · Page 2 of 5
46 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-05 | CCCC | Grant (A) | — | $0 | EDGAR |
| 2020-10-01 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Disp (D) | −41,844 | $0 | EDGAR |
| 2020-06-24 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-09 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Mixed | +9,254 | $21 | EDGAR |
| 2019-11-13 | CAH | Grant (A) | +3,424 | $0 | EDGAR |
| 2019-06-21 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Mixed | +4,356 | $0 | EDGAR |
| 2019-06-12 | MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-20 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Mixed | +7,000 | -$11.6K | EDGAR |
| 2018-12-03 | MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-13 | CAH | Grant (A) | +3,164 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.